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Characterization of cervico-vaginal 
microbiota in women developing 
persistent high-risk Human 
Papillomavirus infection
Monica Di Paola1, Cristina Sani2, Ann Maria Clemente3, Anna Iossa4, Eloisa Perissi  3, 
Giuseppe Castronovo3, Michele Tanturli  6, Damariz Rivero5, Federico Cozzolino6, Duccio 
Cavalieri  5, Francesca Carozzi2, Carlotta De Filippo  7 & Maria Gabriella Torcia3
Changes in cervico-vaginal microbiota with Lactobacillus depletion and increased microbial diversity 
facilitate human papillomavirus (HPV) infection and might be involved in viral persistence and cancer 
development. To define the microbial Community State Types (CSTs) associated with high-risk HPV−
persistence, we analysed 55 cervico-vaginal samples from HPV positive (HPV+) women out of 1029 
screened women and performed pyrosequencing of 16S rDNA. A total of 17 samples from age-matched 
HPV negative (HPV−) women were used as control. Clearance or Persistence groups were defined by 
recalling women after one year for HPV screening and genotyping. A CST IV subgroup, with bacterial 
genera such as Gardnerella, Prevotella, Megasphoera, Atopobium, frequently associated with anaerobic 
consortium in bacterial vaginosis (BV), was present at baseline sampling in 43% of women in Persistence 
group, and only in 7.4% of women in Clearance group. Atopobium genus was significantly enriched in 
Persistence group compared to the other groups. Sialidase-encoding gene from Gardnerella vaginalis, 
involved in biofilm formation, was significantly more represented in Persistence group compared to 
the other groups. Based on these data, we consider the CST IV-BV as a risk factor for HPV persistence 
and we propose Atopobium spp and sialidase gene from G. vaginalis as microbial markers of HPV−
persistence.
Cervical cancer (CC) is one of the most common cancer in women, with an estimated incidence of 485 000 new 
cases and 236 000 deaths in 20131, causing 6.9 million disability-adjusted life-years (DALYs). Persistence of onco-
genic human papillomavirus (HPV) infection contribute to the development of CC.
While the virus is cleared in more than 90% of infections within 6–18 months2–4, viral persistence occurs in 
almost 10% of infected women. The factors responsible of persistence, as well those that promote and initiate the 
carcinogenesis process, need to be fully elucidated. Many other factors such as immunodeficiency, age, smoking, 
oral contraceptives and Chlamydia trachomatis infection are related with higher persistence rates5, 6. Recently, 
several scientific reports indicated the role of vaginal microbiota in the acquisition and persistence of HPV and 
risk of CC development7.
In the majority of human body sites, highly diverse microbial communities are generally considered a signa-
ture of health8, 9. However, in the vaginal environment, health is commonly associated with low microbial diver-
sity and prevalence of only a few species of Lactobacillus10–13. Lactobacillus spp. prevent colonization of exogenous 
pathogens by producing lactic acid, bacteriocins and reactive oxygen species (ROS), and compete with them for 
1Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of 
Florence, Meyer Children Hospital, Florence, Italy. 2S.C. Screening e Prevenzione Secondaria, Istituto per lo Studio 
e la Prevenzione Oncologica (ISPO), Florence, Italy. 3Department of Experimental and Clinical Medicine, University 
of Florence, Florence, Italy. 4Laboratorio Regionale HPV e Biologia Molecolare, LRPO, Istituto per lo Studio e la 
Prevenzione Oncologica (ISPO), Florence, Italy. 5Department of Biology, University of Florence, Florence, Italy. 
6Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy. 7Institute 
of Biology and Agrarian Biotechnology (IBBA), National Research Council (CNR), Pisa, Italy. Correspondence 
and requests for materials should be addressed to F.C. (email: f.carozzi@ispo.toscana.it) or C.D. (email: carlotta.
defilippo@ibba.cnr.it) or M.G.T. (email: maria.torcia@unifi.it)
Received: 23 May 2017
Accepted: 31 July 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENTIFIC REPoRTS | 7: 10200  | DOI:10.1038/s41598-017-09842-6
adherence sites to mucous layer13–15. Five major community-state types (CSTs) discriminate vaginal microbiota 
in healthy women11. Lactobacillus crispatus, L. gasseri, L. iners and L. jensenii dominate CST I, II, III and V respec-
tively, while depletion of Lactobacilli identifies CST IV11. In previous studies differences in vaginal microbiota 
by ethnicity was observed16. African American women may have increased L. iners and decreased L. crispatus 
compared with Caucasian women16, 17.
Anaerobic bacterial species of Gardnerella, Prevotella, Peptostreptococcus genera and/or aerobic bacteria of 
Enterobacteriacee family usually populate vaginal environment depleted of Lactobacillus species18–20.
CST IV is frequently associated with bacterial vaginosis (BV), the most common vaginal infection in women 
of reproductive age7. In this disorder Atopobium vaginae, Clostridiales and selected Gardnerella vaginalis strains 
usually form biofilm on the vaginal epithelium, resistant to antibiotic therapies21.
BV emerged as a public health problem due to its association with sexual transmitted infections including 
human immunodeficiency virus (HIV) and HPV22–26. CST IV is also frequent in aerobic vaginitis (AV). In 
this disorder, Lactobacillus spp. are predominantly replaced with enteric commensals or pathogens. Group B 
Streptococci (GBS), Escherichia coli, and Staphylococcus aureus are microorganisms most frequently associated 
with AV27–30.
In this paper, to define the Community State Types (CSTs) associated with HPV-persistence, we used 
cervico-vaginal samples collected in a study for HPV screening program. Cervico-vaginal microbiota was char-
acterized by metagenomic analysis in samples of HPV positive women and in HPV negative, selected as control. 
Microbial profiles were associated with viral clearance or persistence.
Results
Study population. Cervico-vaginal samples were collected in the contest of a pilot study aimed to evaluate 
the efficacy of HPV test in a primary screening program involving 1029 women aged between 26–64 years old 
(see Methods).
A total of 55/1029 samples were positive for high risk HPV (HR-HPV+) at baseline screening. We were able 
to determine the HPV genotype in 50/55 samples collected at baseline screening and no significant prevalence of 
HPV genotype was recorded. Multiple HPV genotype were present in 13/50 samples (Supplementary Table S1).
All HR-HPV+ women attended the one-year follow up visit and were subjected to a second HR-HPV assay. 
The results of the second assay were used to stratify the baseline sampling in (i) Clearance Group (n = 27), 
HR-HPV+ women in which infection clears and had no evidence of HR-HPV DNA after one year; (ii) Persistence 
group (n = 28), HR-HPV+ women who developed persistent infection and maintained the expression of at least 
one of HPV-DNA genotypes revealed at baseline sampling. HR-HPV+ women were triaged to cytological testing. 
When Atypical Squamous Cells of Undetermined Significance (ASC-US) or a more severe lesion was ascertained, 
women were referred for colposcopy to define the grade (low or high) of lesions (see Methods). We reported 
Cervical Intraepithelial Neoplasia grade 1 (CIN1) and/or condiloma in 6 out of 28 (21.4%) and CIN grade 2 
(CIN2) in 2 out of 28 (7.14%), as shown in Supplementary Table S1.
A total of 17 samples from HPV negative (HPV−) women matched for age were selected as control group. All 
the available epidemiologic and clinical information about the enrolled women were reported in Table 1, as well 
as the HPV genotyping and the results of colposcopy at one-year follow up in Supplementary Table S1.
Cervico-vaginal microbiota characterization. Meta-taxonomic investigation of cervico-vaginal micro-
biota was performed via pyrosequencing of the V3-V5 hypervariable region of 16S rDNA gene, amplified in 
DNA from samples of HPV+ and HPV−women, as controls. In Supplementary Fig. S1A–C and Table S2A–D, 
we reported taxonomic profiles at phylum, family, genus level in all enrolled women.
As expected, Lactobacillus represented the most abundant genus of cervico-vaginal microbiota in the three 
groups (Supplementary Table S2E). However, differences in the distribution of Lactobacillus species were found 
(Table 2). L. crispatus was the most abundant Lactobacillus species in the Control and in Clearance group (Table 2 
and Supplementary Table S2E).
When a depletion in Lactobacillus spp. (<60% of relative abundance for sample) was observed, enrichment 
in aerobic and anaerobic bacteria, likely derived from gut environment or faecal contamination, was found in the 
three groups. In particular, bacterial genera such as Gardnerella, Prevotella, Atopobium, Escherichia/Shigella and 
Streptococcus,associated with bacterial vaginosis11, 22, 23, 31, were frequently found in our cohorts (Table 2).
Characteristics
HPV+ Clearance 
group (n = 27)
HPV+ Persistence 
group (n = 28)
HPV−Control 
group(n = 17)
Ethnicity Caucasian Caucasian Caucasian
Age range (mean ± se) 26–64 (45 ± 11) 26–56 (41 ± 9) 27–57 (43 ± 9)
Postmenopausal, n (%) 7 (25.9%) 4 (14.8%) 4 (23.5%)
Available HPV genotyping, n (%) 23 (85.2%) 27 (96.4%) 0 (0%)
Colposcopy report (after one year), n (%) 0 (0%)
CIN1 6 (21.4%)
0 (0%)CIN2 2 (7.14%)
CIN3 1 (3.5%)
Table 1. Summary of the characteristics available for the women in the three group (Clearance, Persistence, and 
Control). For age range, mean and standard error are indicated. With n (%), number of women and percentage 
are reported.
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To estimate differences in microbial diversity among groups, we measured alpha diversity, based on the num-
ber of Operational Taxonomic Units (OTUs), Chao1 and Shannon indices. We observed that biodiversity was 
higher in the group of HPV+ women and, in particular, in samples from Persistence group compared to Control 
group (Fig. 1). However, the differences were not statistical significant, due to high variability observed among 
samples.
Evaluation of rarefaction curves (Supplementary Fig. S2A and B), calculated by number of observed OTUs for 
different values of the rarefaction depth for each sequenced sample showed that the curves tend to reach a plateau, 
indicating that the obtained sequences were sufficient to cover the real biodiversity.
To investigate microbial communities populating vaginal environment following Lactobacillus depletion 
in the three groups of women, microbial abundances were divided into independent data matrices (Clearance, 
Persistence, Control groups) and pairwise Spearman’s correlation was performed with two-tailed probability 
of t for each correlation. This analysis indicated that few genera of anaerobic bacteria (Prevotella, Gardnerella, 
Atopobium, Dialister) significantly correlated with depletion in Lactobacillus spp. in the Persistence group. In 
contrast, Streptococcus, Streptophita, Aerococcus, and numerous genera from Enterobacteriacee family significantly 
correlated with Lactobacillus depletion in the Clearance and Control groups (Fig. 2).
These data strongly suggested that microbiota composition, following the depletion of protective Lactobacillus 
species, is different in the three groups and that peculiar microbial profiles may affect the outcome of viral 
infection.
CST distribution in patients with different outcome of HPV infection. Based on taxonomic distri-
bution and accordingly with previous studies11, we identified four major groups of microbial communities (CSTs) 
which were designated as CST I, II, III, IV, according to Ravel and Mitra7, 29, 32. Performing hierarchical clustering 
analysis of the samples based on taxonomic abundances in each enrolled women we found association with HPV 
status, age range and CSTs (Fig. 3). CST I was dominated by L. crispatus, CST II by L. gasseri, while CST III by L. 
iners. CST IV was characterized by a paucity of Lactobacillus spp. (lower than 60%) and by a wide array of strict 
or facultative anaerobes. Most of CST IV samples were dominated by anaerobic bacteria belonging to genera 
Gardnerella, Prevotella, Atopobium, Sneathia, which are frequently found in women with bacterial vaginosis (BV). 
We named this subgroup of CST IV as CST IV-BV.
The remaining samples ascribed to CST IV showed Lactobacillus depletion (<60%) and a mixture of aer-
obic and anaerobic bacteria of the genera Pseudomonas, Brevibacterium, Peptostreptococcus, Enterococcus, 
Streptococcus, Propionibacterium, Bifidobacterium, Shigella. Differently than CST IV-BV, strictly anaerobic bac-
teria of the Gardnerella, Prevotella, Atopobium, Megasphoera genera were absent or poorly represented. This sub-
group of CST IV was named CST IV-AV.
OTU HPV+ Clearance group HPV+ Persistence group HPV− Control group
Firmicutes|Lactobacillus 53.1% 50.3% 57.3%
Firmicutes|Lactobacillus|crispatus* 28.5% 16.7% 29.9%
Firmicutes|Lactobacillus|gasseri* 7.78% 3.54% 3.32%
Firmicutes|Lactobacillus|iners* 16.5% 29.8% 23.7%
Firmicutes|Lactobacillus|jensenii* 0.01% 0.04% 0.01%
Actinobacteria|Gardnerella 6.2% 18.9% 12.5%
Actinobacteria|Bifidobacterium 9.2% 3.0% 10.8%
Bacteroidetes|Prevotella 3.0% 6.1% 4.5%
Actinobacteria|Atopobium 1.3% 5.5% 1.7%
Proteobacteria|Escherichia/Shigella 7.6% 0.2% 0.1%
Firmicutes|Streptococcus 1.9% 1.2% 1.2%
Proteobacteria|Gluconacetobacter 1.3% 1.3% 1.1%
Proteobacteria|Sphingomonas 1.2% 1.3% 1.0%
Actinobacteria|Propionibacterium 1.7% 0.6% 1.5%
Fusobacteria|Sneathia 0.3% 2.2% 0.0%
Firmicutes|Pediococcus 0.9% 1.1% 0.8%
Firmicutes|Megasphaera 1.2% 1.1% 0.0%
Cyanobacteria|Streptophyta 0.8% 0.8% 0.8%
Actinobacteria|Brevibacterium 1.2% 0.5% 0.0%
Proteobacteria|Pseudomonas 0.8% 0.4% 0.3%
Actinobacteria|Corynebacterium 0.4% 0.5% 0.3%
Proteobacteria|Gluconobacter 0.3% 0.3% 0.3%
Firmicutes|Aerococcus 0.1% 0.0% 1.1%
Firmicutes|Enterococcus 0.6% 0.1% 0.0%
Table 2. Average of relative abundances of the 20 prevalent genera in cervico-vaginal microbiota in the three 
groups. *Indicated the most abundant species of Lactobacillus were reported.
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Figure 1. Alpha diversity measures. Box plots of observed OTUs, Chao 1, and Shannon index in the three 
groups of women. Pairwise comparisons by using the Wilcoxon rank sum test were not significant.
Figure 2. Bacterial taxa significantly correlating with reduction of Lactobacillus. Spearman's analysis of 
microbial profiles associated with Lactobacillus depletion in the three groups. Microbial abundance data 
were divided into independent data matrices (Clearance, Persistence and Controls) and pairwise Spearman’s 
correlation was performed with two-tailed probability of t for each correlation.
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We observed an increased frequency of CST IV-BV (42.9%) in Persistence group compared either with 
Clearance group (7.4%) or with Control group (11.7%). These data (Fig. 4A and Supplementary Table S3) strongly 
suggested that CST IV-BV may be a risk factor for the persistence of HR-HPV infection and indeed statistical 
analysis revealed an odds ratio = 9.38 (95% confidence interval 1.85–47.52, p = 0.026; Fig. 4B). Furthermore, we 
observed that two women from Persistence group, annotated as CST III, also showed high percentage (≥40%) of 
anaerobic microbial communities typical of CST IV-BV.
To rule out that these data are mainly determined by the high frequency of CST-IV in post-menopausal 
women, we repeated the analysis considering only women in reproductive age exposed to HPV infection. The 
results obtained confirmed that CST IV-BV is significantly correlated to viral persistence in this group of women 
(odd ratio 7.08 at 95% confidence interval 1.31–38.33, p = 0.014).
Alpha diversity analysis of the CST-IV subtypes showed lower species richness in CST IV-BV compared to 
CST IV-AV (Fig. 4C), especially in Persistence group. Although the differences among the groups did not reach 
statistical significance, these data suggest that, in addition to the reduction in Lactobacillus species, only selected 
microbial communities (CST IV-BV) play a role in the persistence of viral infection.
Finally, to evaluate variability of microbial communities among groups, we performed beta diversity analysis 
by using Principal Coordinates Analysis (PCoA) and Non-metric Multi Dimensional Scaling (NMDS), based on 
Bray-Curtis dissimilarities (Fig. 5 and Supplementary Fig. S3). By PERMANOVA analysis, we observed that sam-
ples distribution of the different groups was significantly correlated with CSTs (p = 0.001), age range of women 
(p = 0.009) or for both CST and age range (p = 0.002). In contrast, microbial diversity was not dependent on 
reproductive age (Supplementary Fig. S4).
Figure 3. Survey of bacterial abundances in the enrolled women. Heatmap of the 50 most abundant bacterial 
taxa in cervico-vaginal microbiota of all enrolled women. For bacterial abundance taxa colour-scale bar 
indicates the number of sequence reads (from 0 up to 15400 reads). Dendogram was obtained by hierarchical 
clustering and was used to cluster samples of cervico-vaginal microbiota based on average distances calculated 
by Pearson correlation (by ClustVis tool). For each sample, we indicated age range (yellow = 26–49, and 
black = 50–64 age range), HPV status (white = HPV−, green = HPV+ Clearance, and red = HPV+ Persistence) 
of all enrolled women and CST groups (from I to IV).
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Key phylotype in persistent HPV infection. To define potential metagenomic biomarkers, useful as 
classifiers, and to evaluate differences in abundances between assigned taxa with respect to HPV status and/or 
to clearance/persistence, we performed Linear Discriminant Analysis (LDA) Effect Size (LEfSe) analysis (see 
Methods). In agreement with previous reports we found a significant enrichment in Sneathia (Leptotrichiaceae 
family)33, Megasphaera (Veillonellaceae family) and Pseudomonas (Pseudomonaceae family)34 and also in 
Pediococcus (Lactobacillaceae family) and Brevibacterium (Brevibacteriaceae family) in the group of HR-HPV+ 
women compared to HPV− controls (Fig. 6A). Furthermore, considering only HPV+ women, we found enrich-
ment in Atopobium as well as a lower abundance in Faecalibacterium genus in the Persistence group compared to 
the Clearance group (Fig. 6B).
Sialidase-encoding gene from G. vaginalis as potential marker of viral persistence. Gardnerella 
is one of the dominant genera in our survey. It is known that selected strains of G. vaginalis adopt the biofilm 
mode of growth as a survival strategy35, 36 and through symbiotic relationships with normally dormant vaginal 
anaerobes (Prevotella, Atopobium) may lead to increase of the latter. The production of sialidase is an impor-
tant step in the biofilm formation37. To investigate whether sialidase-producing Gardnerella spp. were differ-
ently represented in microbial communities of the four CSTs, we studied the presence and the relative amount 
of sialidase-encoding gene (GVSI) by quantitative Real Time PCR. The amount of sialidase-encoding gene of 
G. vaginalis was significantly higher in the Persistence group compared with Clearance group (Fig. 7; Mood’s 
median test, MD Test p = 0.025) and especially in CST IV-BV samples (odds ratio = 12 1.58–91.09, 95% CI p = 0.010), 
Figure 4. CST distribution among the groups. (A) Pie charts of the frequency of CSTs in the three groups. (B) 
Odds ratio. Bars indicate 95% confidence intervals. Red line indicates null value (OR = 1.0); *indicates p < 0.05. 
(C) Alpha diversity measure in cervico-vaginal microbiota in CST IV subgroup. Box plots of observed OTUs, 
Chao 1, and Shannon index in the three groups of patients. Pairwise comparisons by using the Wilcoxon rank 
sum test were not significant.
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indicating a strong association among species of G. vaginalis producing sialidase, relevant for biofilm formation, 
CST IV-BV and HPV persistence.
Discussion
Metagenomics has been previously used to assess the impact of vaginal microbiota composition in HPV infec-
tion. Most of these studies showed lower proportion of Lactobacillus spp. and higher diversity in HPV-infected 
women compared to HPV-negative32, 38.
Brotman and co-workers39 performed a large longitudinal study in a cohort of 32 premenopausal women 
using self-sampling at twice-weekly intervals over the course of 16 weeks. The results of this study showed that 
CST III (dominance of L. iners) and IV (depletion in Lactobacilli) were most likely associated with HPV infec-
tion39, 40.
In our survey, the use of cervico-vaginal samples collected in the course of a primary screening and stored in a 
biological bank, gave us the opportunity to discriminate samples from women in which viral infection was cleared 
at one-year follow up, from those who developed persistent infection and to evaluate cervico-vaginal microbial 
profiles as a predictive risk factor of HPV persistence.
Microbiota characterization was performed at baseline sampling in all of HPV+ women (55/1029) involved 
in the study and HPV negative as control, with age between 26–64 years, in order to evaluate microbial profiles 
independently on the reproductive age.
In accordance with previous studies, the higher alpha diversity observed in the group of HPV+ 
women and especially in the Persistence group suggests that increase in species richness (compared to a 
Lactobacillus-dominated microbiota) could become a negative indicator in the more simplified vaginal 
Figure 5. Beta diversity measure. (A,B) PCoA, based on Bray Curtis dissimilarities, correlated with CSTs 
and Age range. (A) Samples belonging to different CSTs are indicated with different colour dots. (B) CSTs 
are indicated with different forms (dots, triangles, cross-marks and squares). Age range are indicated with 
different blue colour-scales. p = 0.001 for CST, p = 0.002 for Age and p = 0.009 for Age:CST, respectively by 
PERMANOVA using the adonis() function with 999 permutations.
Figure 6. Metagenomic biomarker discovery by LEfSe analysis. Enrichment in bacterial taxa between (A) 
HPV+ and HPV− women; (B) HPV+ (Clearance) and HPV+ (Persistence) women. Results indicated the 
statistically significant taxa enrichment among groups (Alpha value = 0.05 for the factorial Kruskal-Wallis test 
among classes). The threshold for the logarithmic LDA score was 2.0.
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communities. When compared with HPV− women, we found selected genera (Sneathia, Megasphaera and 
Enterobacteriaceae) significantly enriched in the HPV+ women. These results are in agreement with those report-
ing the prevalence of Sneathia in HPV+ patients with Squamous Intraepithelial Lesion (SIL)34.
The classification of cervico-vaginal microbial communities based on the CSTs reported by Ravel et al.11 allows 
us to define the CST IV (with Lactobacillus depletion) as the most represented bacterial community in HR-HPV 
infected women compared to negative controls. However, two subgroups of CST IV could be identified in our 
records. Few strictly anaerobic bacteria of the Gardnerella, Prevotella, Atopobium, Megasphera, Dialister gen-
era dominated CST IV in women developing persistent infection. We referred this type of CST as CST IV-BV, 
since the same bacterial communities are frequently found in women with bacterial vaginosis (BV). A mix-
ture of aerobic and anaerobic bacteria including Pseudomonas, Brevibacterium, Peptostreptococcus, Enterococcus, 
Streptococcus, Propionibacterium, Bifidobacterium and Shigella, namely CST IV-AV subtype, was prevalent in 
the Clearance group. The differences among the groups in bacterial communities populating vaginal environ-
ment, following depletion in Lactobacillus species, were evident through the Spearman's correlation analysis. 
Beta diversity analysis showed that, microbial variability among samples is correlated with CSTs and age range of 
women. However, the adoption of the CST classification proposed by Ravel11 allowed us to perform a risk asso-
ciation analysis, and despite the limited sample size, we found a significant association between CST IV-BV and 
the persistence of HR-HPV infection, which was not dependent on the reproductive age. Unfortunately, the lack 
of additional clinical and behavioural information of the enrolled women did not allow the revealing of further 
correlations considering CST subgroups and in particular with CST IV-BV.
However, we observed a very low alpha diversity in the CST IV-BV in women of the Persistence group, indi-
cating that only a limited number of bacterial genera are likely involved in viral persistence. Based on our results, 
we suggest that CST IV-BV subtype play a role in viral persistence. To define potential metagenomic biomark-
ers of persistent infection, we identified Atopobium as key phylotype in the Persistence group compared to the 
Clearance group.
Finally, to define molecular markers associated with viral persistence, we evaluated the relative amount of 
sialidase-encoding gene from Gardnerella vaginalis species in the three groups of women. As known, selected 
strains of G. vaginalis are able to form biofilm and the production of sialidase is an important step in the bio-
film formation37. This enzyme facilitates the destruction of the protective mucus layer on the vaginal epithelium 
allowing resistant adhesion of bacteria, which can start to form biofilm35, 36. The observed higher amount of 
sialidase-encoding gene in the Persistence group compared to other groups and in particular the prevalence 
in CST IV-BV suggest that sialidase-producing G. vaginalis strains are likely involved in formation of biofilm 
entrapping anaerobic pathobionts, such as Prevotella and Atopobium, favouring their overgrowth41, and that these 
biofilms may contribute to viral persistence.
Atopobium vaginae, which is significantly more represented in microbiota of women in Persistence group 
compared to Clearance group, may play a role in the disruption of epithelial barriers42, favouring either HPV 
infections or viral dissemination. A recent study reports that anaerobes as Prevotella, Gardnerella, Atopobium, 
Sneathia, induce a strong inflammation in vaginal environment with high recruitment of T-helper 17 lympho-
cytes, which favours HIV infection26. Although no differences in lymphoid population were associated with 
clearance or persistence of HPV infection43, a high concentration of inflammation markers (IP-10 and MIG 
chemokines) was found in the vaginal environment of women who cleared the virus. The differential inflamma-
tory potential of bacterial taxa populating vaginal environment in the Clearance and Persistence groups need 
to be elucidated. While a high inflammatory environment could facilitate viral clearance, immune-modulating 
bacterial genera, such as Faecalibacterium44, 45, could play a role in the progression of disease in later stages of 
Figure 7. Quantitative RT-PCR for G. vaginalis sialidase-encoding gene. Data are expressed as relative amounts 
of sialidase-encoding gene. Box chart extends from SE with a lane indicating median value and an asterisk as 
mean value; +symbols indicate range values. Statistical analysis was performed by Mood’s Median Test and 
p < 0.05 was considered significant.
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infection. Further investigations are needed to establish the role of bacterial biofilms and/or the induction of 
immunomodulation in HPV disease.
Finally, although we could not ascertain microbiota stability in our patients during one-year intercourse, we 
can conclude that the early cervico-vaginal microbiota characterization may help to discriminate women at risk 
to develop persistent HPV infection and provide useful insights to develop new therapeutic strategies, modifying 
the vaginal microbiota ecosystem.
Methods
Population study. A total of 1029 women, resident in Florence district (Italy) in both reproductive and 
post-menopausal age, who never received HPV vaccine, were enrolled in a HPV DNA based cervical cancer 
screening program in the contest of pilot study aimed to evaluate efficacy of HPV testing for the detection of 
invasive cervical cancer and cervical intrahepithelial neoplasia. The study was approved by the Ethics Committee 
of Azienda USL 10, Florence, Italy (Protocol ref. 263/2009). The protocol and the methods were performed in 
accordance with relevant guidelines and regulations. Informed consent for using biological samples for scien-
tific investigations, including microbiota characterization, was obtained from all women at the time of the first 
screening.
All enrolled women were of Caucasian ethnicity. Group Age ranged between 26–64 years. Exclusion criteria 
were: (i) pregnancy (ii) HIV infection (ii) immunodeficiency-related diseases, including AIDS. Abstinence from 
sex and from using vaginal antibiotics and/or vaginal washes was required until three days before collection.
Cervico-vaginal samples were collected in Specimen Transport Medium (STM; Qiagen, Milano Italy) by 
trained midwives at Istituto per lo Studio e la Prevenzione Oncologica (ISPO; Florence, Italy).
HR-HPV status was determined through HR-HC2 assay (see paragraph below) and the remaining samples 
were stored at −80 °C for bacterial genomic DNA extraction.
Samples from all of HPV+ women (55/1029) and from 17 selected age-matched HPV− women (who gave 
consensus for scientific investigations) were used for microbiota characterization. All information obtained by 
consensus are summarized in Table 1. No further information could be acquired later.
HR-HPV+ women were not directly referred to colposcopy but were triaged according to cytological testing. 
If the result of this test was abnormal (Atypical Squamous Cells of Undetermined Significance -ASC-US- or a 
more severe lesion) the women were immediately referred to colposcopy. If cytology was normal, the women 
were invited to repeat a new HPV test after one year, following the HTA protocol46. When Atypical Squamous 
Cells of Undetermined Significance (ASC-US) or a more severe lesion was ascertained, women were referred for 
colposcopy to define the grade (low or high) of lesions, according to the Italian cervical cancer screening protocol 
(Ministero della Salute Italiana, Italy). Furthermore, HPV genotyping was used to confirm the viral persistence.
Supplementary Table S1 shows the distribution of age, HPV status at baseline screening and at follow-up, the 
genotype(s) of HPV for each woman, as well as the colposcopy report.
Bacterial DNA extraction. Bacterial genomic DNA was extracted from the cervico-vaginal samples stored 
at −80 °C, by using a QiAmp Mini DNA kit (Qiagen, Milano, Italy) as previously described38. Quality control 
was carried out by gel electrophoresis and measuring ng/µl of DNA and 260/280 OD at Nanodrop 1000 (Thermo 
Scientific).
HPV-assay and HPV genotyping. HPV DNA test was performed according to manufacturer’s guidelines 
using the Hybrid Capture 2 assay (HC2; Qiagen, Milano, Italy).
The HC2 assay is a nucleic acid hybridization assay with signal amplification using microplate chemilumines-
cence for the qualitative detection of thirteen high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) of 
HPV DNA in cervical specimens.
Genotyping was performed on HR-HC2 positive samples. Specific genotyping, which identifies thirty-one 
HPV types, was performed by amplifying the target DNA with PGMY09/11 and HLA biotinylated primers, using 
the validated method of the WHO HPV LabNet group47.
Pyrosequencing and data analysis. We amplified the 16S rRNA gene by using primer set specific for 
V3-V5 hypervariable regions, and the FastStart High Fidelity PCR system (Roche Life Science, Milano, Italy) as 
described in Strati et al.48. The 454 pyrosequencing was carried out on the GS FLX+ system using the XL+ chem-
istry following the manufacturer’s recommendations.
Pyrosequencing resulted in a total of 2,112,426 16S rDNA reads with a mean of 26,405 sequences per sample. 
Average sequence lengths were 589 nt (±SD 28.4), 591 nt (±SD 25.7) and 594 nt (±SD 24.39) for the first, second 
and third run, respectively. Raw 454 files were demultiplexed using Roche’s.sff file software, and made availa-
ble at the European Nucleotide Archive (http://www.ebi.ac.uk/ena/data/view/PRJEB18720) under the accession 
study PRJEB18720. Pre-processing of the reads was performed using the MICCA pipeline (version 0.1, http://
www.micca.org). Trimming of the primers and quality filtering were performed using micca-preproc, truncating 
reads shorter than 280 nt (quality threshold = 18; http://micca.org/docs/0.1/command_ref/micca_preproc.html; 
Supplementary Table S4). Denovo sequence clustering, chimera filtering and taxonomy assignment were per-
formed by micca-otu-denovo (parameters −s 0.97 −c). Operational Taxonomic Units (OTUs) were assigned by 
clustering the sequences with a threshold of 97% pair-wise identity. The representative sequences were classified 
using the RDP classifier version 2.7 against RDP 11 database (update 5) of 16S rRNA. Template-guided multiple 
sequence alignment was performed using PyNAST (version 0.1) against the multiple alignment of the Greengenes 
16S rRNA gene database (release 13_05) andfiltering at 97% similarity. A phylogenetic tree was inferred using 
FastTree and micca-phylogeny (parameters: -a template-template-min-perc 50). Rarefaction was performed in 
order to reduce the sampling heterogeneity. A total of 15,400 sequences per sample was obtained.
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Observed OTUs, Chao1 index, Shannon entropy (indicators of alpha diversity) and Bray-Curtis dissimilarities 
(indicators of beta diversity) were calculated using the phyloseq package of the R software suite.
Community State Type (CST) of each cervico-vaginal microbiota was defined considering the relative abun-
dance of Lactobacillus spp. as >60%, and aerobic and anaerobic bacteria ranging from 14 to 40%.
To evaluate the differences in overall bacterial community composition, Principal Coordinates Analysis 
(PCoA) and Non-metric Multidimensional Scaling (NMDS), based on Bray-Curtis dissimilarities were per-
formed. The significance of between-groups differentiation (CSTs, Age range, reproductive and menopausal age) 
was assessed by PERMANOVA, Adonis() function, using the R package vegan with 999 permutations.
By Clustvis tool49, heatmap of the relative abundances of bacterial taxa was generated. Variables such as HPV 
status, CST, age range of the women were associated with the respective microbiota sample. Heatmap was sup-
ported by a dendrogram obtained with hierarchical clustering of the samples and based on average distances 
among samples calculated by Pearson correlation.
Quantitative Real Time PCR of sialidase-encoding gene from Gardnerella vaginalis. 
Quantitative Real Time PCR (RT q-PCR) of sialidase-encoding gene (GVSI) was performed by using 
Platinum TaqUniversal SYBR® green supermix (InvitrogenBiorad) and primers specific for G. vaginalis 
sialidase-encoding gene (Fw-5′GGGTTTATGCACACGCTT TT-3′ and Rv-5′GAAAATGCAGACAACGC 
AGA-3′)50 and universal bacterial 16 S rRNA gene (from E. coli; Fw-5′AGAGTTTGATCCTGGCTCAG-3′ and 
Rv-5′GGACTACCAGGGTATCTAAT-3′) as reference of the total bacterial community51. RT q-PCR was per-
formed in Applied Biosystem 7900 instrument following these conditions: 50 °C for 2′; 95 °C for 10′, 40 cycles of 
denaturation at 95 °C for 15″, annealing at 55 °C for 30″, and extension at 68 °C for 30″ followed by a dissociation 
stage :95° for 15″; 60° for 15″ and 95° for 15″ with a rampe rate of 2%. Samples with a melting temperature (Tm) 
value at 84° for sialidase-encoding gene (n = 26) and between 87 and 91 °C for the 16S r RNA gene were consid-
ered positive (n = 55).
Results are reported as relative amount of DNA calculated as 2−ΔCT, with ΔCT = CT sialidase − CT 16S.
Statistical analysis. Metagenomic biomarker discovery and related statistical significance were assessed 
using relative taxonomic abundances analysed according to the Linear Discriminant Analysis (LDA) Effect Size 
(LEfSe) method52. In LEfSe, Kruskal–Wallis rank-sum test is used to identify features with significantly different 
taxa abundances among groups, and LDA to calculate the size effect of each feature. An alpha significance level 
of 0.05, either for the factorial Kruskal-Wallis test among classes or for the pairwise Wilcoxon test between sub-
classes, and a size-effect threshold of 2.0 on the logarithmic LDA score were used for discriminative microbial 
biomarkers.
For correlation analysis, microbiota abundance data were divided into independent data matrices (Clearance 
group, Persistence group and HPV− group, as control). The correlation coefficients and significant negative cor-
relations (p < 0.05) between Lactobacillus abundance data and all the other taxa were calculated using the pair-
wise Spearman’s correlation and two-tailed probability of t for each correlation.
Odd ratio with 95% confidence interval was calculated to correlate CSTs with HPV clearance and persistence 
in all women population and considering also the only women in reproductive age. P < 0.05 was considered sta-
tistically significant.
Statistical analysis of RTq-PCR of sialidase-encoding gene was performed with non parametric Mood’s 
Median test (MDTest) and Wilcoxon Signed Rank test using the Origin software. P < 0.05 was considered statis-
tically significant.
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